NM_148960.3:c.*1018G>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_148960.3(CLDN19):​c.*1018G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0217 in 152,634 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.022 ( 65 hom., cov: 32)
Exomes 𝑓: 0.020 ( 0 hom. )

Consequence

CLDN19
NM_148960.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.432

Publications

2 publications found
Variant links:
Genes affected
CLDN19 (HGNC:2040): (claudin 19) The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]
CLDN19 Gene-Disease associations (from GenCC):
  • renal hypomagnesemia 5 with ocular involvement
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-42734068-C-A is Benign according to our data. Variant chr1-42734068-C-A is described in ClinVar as Benign. ClinVar VariationId is 297325.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0217 (3298/152190) while in subpopulation SAS AF = 0.0504 (243/4824). AF 95% confidence interval is 0.0452. There are 65 homozygotes in GnomAd4. There are 1629 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 65 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_148960.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLDN19
NM_148960.3
MANE Select
c.*1018G>T
3_prime_UTR
Exon 5 of 5NP_683763.2Q8N6F1-1
CLDN19
NM_001185117.2
c.*1694G>T
3_prime_UTR
Exon 3 of 3NP_001172046.1Q8N6F1-3
CLDN19
NM_001123395.2
c.*1800G>T
3_prime_UTR
Exon 4 of 4NP_001116867.1Q8N6F1-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLDN19
ENST00000296387.6
TSL:2 MANE Select
c.*1018G>T
3_prime_UTR
Exon 5 of 5ENSP00000296387.1Q8N6F1-1
CLDN19
ENST00000539749.5
TSL:2
c.*1694G>T
3_prime_UTR
Exon 3 of 3ENSP00000443229.1Q8N6F1-3

Frequencies

GnomAD3 genomes
AF:
0.0217
AC:
3299
AN:
152072
Hom.:
65
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00575
Gnomad AMI
AF:
0.0844
Gnomad AMR
AF:
0.0181
Gnomad ASJ
AF:
0.0389
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0499
Gnomad FIN
AF:
0.0219
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0297
Gnomad OTH
AF:
0.0306
GnomAD4 exome
AF:
0.0203
AC:
9
AN:
444
Hom.:
0
Cov.:
0
AF XY:
0.0160
AC XY:
5
AN XY:
312
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
10
American (AMR)
AF:
0.00
AC:
0
AN:
6
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.00
AC:
0
AN:
6
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
64
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
6
European-Non Finnish (NFE)
AF:
0.0294
AC:
9
AN:
306
Other (OTH)
AF:
0.00
AC:
0
AN:
42
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0217
AC:
3298
AN:
152190
Hom.:
65
Cov.:
32
AF XY:
0.0219
AC XY:
1629
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.00573
AC:
238
AN:
41528
American (AMR)
AF:
0.0181
AC:
277
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0389
AC:
135
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5162
South Asian (SAS)
AF:
0.0504
AC:
243
AN:
4824
European-Finnish (FIN)
AF:
0.0219
AC:
232
AN:
10592
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0297
AC:
2021
AN:
68002
Other (OTH)
AF:
0.0298
AC:
63
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
166
333
499
666
832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0246
Hom.:
8
Bravo
AF:
0.0207
Asia WGS
AF:
0.0160
AC:
55
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Renal hypomagnesemia 5 with ocular involvement (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.3
DANN
Benign
0.79
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114944537; hg19: chr1-43199739; API